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A B S T R A C T
Ruptured subclavian artery aneurysm (SAA) is extremely rare and it can cause a life-threatening
condition. We described an elderly patient with ruptured SAA who underwent endovascular treatment
successfully. Our case showed that endovascular repair may be one of the options for the treatment of
ruptured SAA when surgical repair is impossible or not indicated for its difﬁculty.
<Learning objective: How to manage ruptured subclavian artery aneurysm by endovascular therapy.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Subclavian artery aneurysm (SAA) is a rare disease. Moreover,
ruptured SAA is extremely rare and it can cause life-threatening
condition. Yet there is no general guideline for management of
ruptured SAA excluding open surgical repair. We described an
elderly patient with ruptured SAA who underwent endovascular
treatment successfully.
Case
A 76-year-old male patient visited the emergency room of our
hospital because of suspected hemoptysis. He had diabetes
mellitus and hypertension on medication. Three years ago, he
was diagnosed with a 2.8-cm-sized left SAA on chest routine CT
scan during routine check-up and was recommended surgical
repair for SAA but refused. After then, we lost track of this patient.
His blood pressure was 130/90 mmHg and pulse rate was 76 beats
per minute. Diffuse haziness was noted at the left upper lung ﬁeld
on chest X-ray. Compared to previous study, thoracic CT
angiography revealed increased size of left SAA from 28 mm to* Corresponding author at: Cardiology Division, Department of Internal Medicine,
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posterior aspect of aneurysm resulting in pseudoaneurysm and
formation of hematoma (Fig. 1A and B). For management of
ruptured SAA, we discussed with a cardiothoracic surgeon.
Aneurysm was noted from proximal segment of left subclavian
artery (LSCA). The cardiothoracic surgeon explained the surgical
procedure, its efﬁcacy and risks. But the patient refused open
surgical repair. For endovascular treatment, however, the length of
proximal landing zone was too short to deploy the stent-graft
(Fig. 1A, arrow). The chance of endoleak after implantation of
stent-graft was high. Fortunately, there was a short narrow portion
of proximal LSCA just before SAA. Our idea was that if we choose
larger stent-graft than the usual case, proximal part might be
sealed completely.
Under local anesthesia, left brachial artery and right femoral
artery were punctured and each 6 and 8F sheaths were inserted.
Angiography showed huge ruptured SAA with extravasation. The
diameter of the narrowed portion of LSCA was 7 cm. After passing
the lesion with 035 inch 300 cm terumo wire (Terumo medical
corporation, Japan), 12 mm  100 mm stent-graft (S & G, Korea)
was delivered via left brachial artery and deployed. Follow-up
angiography noted type Ia endoleak from proximal portion of
stent-graft. Additional ballooning with coda 10 mm  2 mm
balloon (Cook Medical, USA) was performed. Final angiography
showed well-positioned stent-graft without evidence of contrast
media extravasation (Fig. 1C). Follow-up CT angiography per-
formed immediately and at 4 months after procedure showed good reserved.
Fig. 1.
Thoracic CT angiography revealed increased size of left SAA which is starting just above the origin of left subclavian artery (arrow, A) with mural thrombus,
extravasation of contrast media to posterior aspect of aneurysm resulting in pseudoaneurysm and formation of hematoma (asterisk, B). After implantation of
stent-graft, angiography showed well-positioned stent-graft without evidence of contrast media extravasation (C). Follow-up CT angiography performed at
4 months (D) after procedure showed good patency of stent-graft without evidence of any endoleak, stent thrombosis or occlusion.
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thrombosis or occlusion and amount of hemorrhage was decreased
(Fig. 1D). The patient was doing well without any clinical
symptoms or signs.
Discussion
SAA is a rarely reported disease; Dent et al. reported only two
SAA (0.13%) among 1488 cases of aneurysms [1,2] and Paiolero
et al. reported 32 cases of subclavian-axillary artery aneurysm
between 1960 and 1980 at the Mayo Clinic. Out of them, 14 were
located primarily in the subclavian artery [3].
SAA arise from variable causes like atherosclerosis, trauma,
thoracic out syndrome (TOS), collagen disorder, infection and
iatrogenic cause. Before 1980, most SAAs were related to TOS,
infection or atherosclerosis. After 1980 traumatic and iatrogenic
causes were more frequently reported [4].
Up to one third of the patients with SAA are asymptomatic.
Especially, intrathoracic aneurysms tend to be asymptomatic and
they are very difﬁcult to be detected on a physical examination
[5]. In symptomatic patients with SAA, they are mainly present
with a pulsating mass, shoulder pain and non-speciﬁc chest pain.
Local compression, embolization, thrombosis and rupture can also
be found. Local compression symptoms include Horner syndrome,
facial anhydrosis, hoarseness, dysphagia and dyspnea.
SAA with hemoptysis is rarely reported. Hilary et al. reviewed
12 cases of a SAA presenting with massive hemoptysis in theliterature. Three cases of them involved the right subclavian and
9 involved the left subclavian artery. Three cases were fatal
before receiving treatment. Other cases were managed with open
repair, endovascular repair, hybrid repair, and embolization.
These cases were mainly associated with documented infection,
lung abscess, or immunosuppression due to chemotherapy
and/or malignancy [6].
Rupture of SAA is a life-threatening and limb-threatening
condition. According to Vierhout et al., rupture was reported in 32
(9%) of 381 SAA patients and six of them underwent a fatal course.
Especially nine survivors have a symptom of hemoptysis, which
was regarded as an early sign of rupture like in our case [4].
Due to the rarity of SAA, treatment guideline of SAA is not
established. Treatment modality is decided by thrombosis, embolic
event and rupture risk accompanied by location and etiology of
SAA. Open surgical repair was the only way to exclude SAA before
endovascular repair was introduced. But, patients present with
SAA are usually critically ill or have severe comorbidity. Since open
surgical repair of the SAA undergoes sternotomy or thoracotomy
according to the need, it is a highly invasive procedure. Therefore it
is favorable that patients receive a minimally invasive treatment
such as an endovascular repair like in our case [7]. Ever since the
mid-1990s, the endovascular repair of SAA-related papers have
been published and they added up to 63 cases until 2010. From
these cases, the notable point is that the endovascular repair not
only had a high rate of immediate success, but also had a high
incidence of thrombosis. Overall complication rate of open and
S. Kim et al. / Journal of Cardiology Cases 11 (2015) 129–131 131endovascular repair was in a similar range. But complication
following endovascular repair seems less severe [4].
In this case, the patient could not receive proper treatment at
the right time because we could not differentiate between
hemoptysis and hematemesis at ﬁrst. It was possible to proceed
on an elective endovascular repair because his vital sign was stable
and there was no active bleeding on CT angiography. From the fact
that this patient showed no special symptom other than
hemoptysis, it is possible to suspect SAA rupture when encoun-
tering any patient with history of SAA presenting with hemoptysis.
This patient had no comorbidity other than diabetes mellitus
and hypertension, but considering the SAA’s proximal location and
invasiveness of open surgery, we proceeded on the endovascular
repair. His left vertebral artery had been occluded at the time of
SAA diagnosis and right vertebral artery was patent. So a bypass
operation was unnecessary. In the aspect of endovascular
treatment, proximal landing zone in this case was relatively short
compared to the usual case, but there was narrowed portion
between aorta and SAA. In this situation it might be possible to
achieve sealing off at landing zone using relatively large-sized stet-
graft like in our case.
In conclusion, our patient was successfully treated with
endovascular repair showing favorable results at follow-up CT
scan. Our case showed that endovascular repair may be one of theoptions for the treatment of ruptured SAA when surgical repair is
impossible or not indicated for its difﬁculty.
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